View monthly record counts
| Month | Records |
|---|---|
| 2 |
Data updated:
| Month | Records |
|---|---|
| 2 |
| # | Country / Region | Records |
|---|---|---|
| 1 | Costa Rica | 2 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300439 | 未列名含有激素或品目29.37其他产品的药品,已配定剂量或制成零售包装 | Medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excluding medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues) | 2 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | FARMACIAS EOS SOCIEDAD ANONIMA | — | 1 |
| 2 | FARMACIAS EOS S.A | COSTA RICA | 1 |
| Date | Apr 13, 2026 | Bill No. | — | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | ASTRAZENCA | Buyer Information | Company Name | FARMACIAS EOS S.A |
| Address | — | Address | — | ||
| Registration No. | — | Registration No. | 310100234614 | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30043910 | HS Description | 未列名含有激素或品目29.37其他产品的药品,已配定剂量或制成零售包装Medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excluding medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues) | |
| Product Description | MEDICAMENTO PARA USO HUMANO : FASLODEX 250 MG/5ML : SM : SM | Brand | SM | ||
| Quantity & Price | Amount | 143,000.00 | Weight | 522 kg | |
| Quantity | 500 Unidad (c/u) | TEU | — | ||
| Shipment Information | Origin Country | GERMANY | Destination Country | COSTA RICA | |
| Port of Loading | — | Destination Port | — | ||
| Loading Place | — | Transport Mode | AIR | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||